Eric Vallieres, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Seattle, WANPI 1881750743
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $124,450 of the $202,362 with a category attached, or 61.5%. AstraZeneca accounts for 75.3% of it on its own, with 17 other manufacturers making up the rest. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 176 payments — averaging $1149.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$152K
- Gyrus ACMI, Inc.$23K
- Merck$16K
- E.r. Squibb & Sons, L.L.C.$3K
- Astrazeneca UK Limited$3K
- Spiration, Inc.$2K
- plus $3K from 12 others
Across 14 payments — averaging $814.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$11K
What the payments were for
- Consulting fees$57,01028%
- Speaking & faculty fees$124,45061%
- Travel & lodging$16,3148%
- Food & beverage$4,5882%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 120 | $152,326 |
| Gyrus ACMI, Inc. | 14 | $23,080 |
| Merck | 16 | $16,388 |
| E.r. Squibb & Sons, L.L.C. | 6 | $3,133 |
| Astrazeneca UK Limited | 2 | $2,925 |
| Spiration, Inc. | 2 | $1,838 |
| Uptake Medical Technology Inc | 1 | $896 |
| Bristol Myers Squibb | 1 | $500 |
| Medtronic | 3 | $335 |
| Atricure, Inc. | 2 | $256 |
| Zimmer Biomet | 1 | $193 |
| Enterra Medical, Inc. | 1 | $167 |
| Boston Scientific | 1 | $143 |
| Intuitive Surgical | 1 | $112 |
| Davol Inc. | 1 | $24 |
| Covidien LP | 1 | $16 |
| Genentech USA, Inc. | 1 | $16 |
| Veran Medical Technologies, Inc. | 2 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$202,362 in reported general payments places this provider in the 95th percentile of 105 thoracic surgery (cardiothoracic vascular surgery) providers in Washington.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Washington →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other thoracic surgery (cardiothoracic vascular surgery) in Seattle
- Glenn BarnhartSeattle$577K
- Eric LehrSeattle$72K
- Thomas VargheseSeattle$22K
- Shakirat OyetunjiSeattle$21K
- Christopher BurkeSeattle$19K
- Mohamed EldeirySeattle$17K
- Ioannis John DemarakosSeattle$15K
- Peter WhiteSeattle$15K
- Joel SternbachSeattle$13K
- Adam BogradSeattle$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.